Lab with white walls, floor, two chairs with lab coats
MRC Lead Apologizes Following Bullying Allegations
In a statement issued by UK Research and Innovation, stem cell biologist Fiona Watt said she was devastated to learn of the impact of her actions and behavior on colleagues.
ABOVE: © ISTOCK.COM, ALVAREZ
MRC Lead Apologizes Following Bullying Allegations
MRC Lead Apologizes Following Bullying Allegations

In a statement issued by UK Research and Innovation, stem cell biologist Fiona Watt said she was devastated to learn of the impact of her actions and behavior on colleagues.

In a statement issued by UK Research and Innovation, stem cell biologist Fiona Watt said she was devastated to learn of the impact of her actions and behavior on colleagues.

ABOVE: © ISTOCK.COM, ALVAREZ

research and development

blue and white building sign
Biden Picks Robert Califf to Head the FDA for a Second Time
Chloe Tenn | Nov 12, 2021
The cardiologist was briefly the FDA Commissioner in the Obama Administration, and now has a second chance to act on plans he tried to implement during his first tenure.
President Biden Proposes Creating Two DARPA-Like Agencies
Lisa Winter | Apr 12, 2021
These new initiatives would tackle problems relating to health and climate.
NSF, National Science Foundation, bill, legislation, Endless Frontier Act, National Science Foundation for the Future Act, innovation, research, funding, science, bipartisan
US Lawmakers Propose Doubling of NSF Funding
Asher Jones | Mar 29, 2021
A bipartisan bill aims to increase the National Science Foundation’s budget over the next five years and form a new technology directorate.
UK Announces “High-Risk, High-Reward” Research Development Agency
Lisa Winter | Feb 23, 2021
The program, known as ARIA, will be independent and scientist-led.
Biopharma Looks to the Netherlands as European Hub
Jef Akst | Feb 1, 2021
The recent move of the European Medicines Agency from London to Amsterdam is a reflection of the city’s vibrant life sciences and health sector and supporting industries.
Biden administration, Trump administration, science policy, politics, research funding, public health, climate change, NSF, NIH, CDC
Science Advocates’ Wishlist for the Biden Administration
Amanda Heidt | Jan 7, 2021
From immigration reform to climate change amelioration, researchers and science policy advocates share their hopes for 2021 and beyond.
Pharma Looks to Outer Space to Boost Drug R&D
Katarina Zimmer | Dec 1, 2020
There are benefits of studying certain biological processes under microgravity, but whether those advantages outweigh the costs of getting experiments off Earth remains to be seen.
The Rise of BCI Enables Advances in Neuroscience
Jef Akst | Oct 1, 2020
A nascent but growing consumer market for brain-computer interface technology is driving the development of sleek new tools for decoding brain activity.
vaccine, Covid-19, coronavirus, SARS-CoV-2, pandemic, self experimentation, polio, poliovirus, yellow fever, Jonas Salk, Joseph Goldberger, George Church
Self-Experimentation in the Time of COVID-19
Amanda Heidt | Aug 6, 2020
Scientists are taking their own vaccines, an ethically murky practice that has a long and sometimes celebrated history in medicine.
UK Announces Fast-Track Visa to Recruit Top Scientists
Ashley Yeager | Aug 9, 2019
Prime Minister Boris Johnson says the immigration program will help the nation remain a science superpower post-Brexit.
EPA Plans to Discontinue a Senior Science Advisor Position
Sukanya Charuchandra | Sep 28, 2018
This change is part of an overhaul taking placing within the research arm of the environmental agency.
Trump Releases Science Spending Priorities for FY2019
Aggie Mika | Aug 18, 2017
In a memo to federal agencies, the administration highlights defense and security, leaves off Earth and climate science, and limits the scope of basic research.
Alphabet Announces Life Sciences
Tracy Vence | Aug 24, 2015
Google’s parent company is launching a research-and-development project as a standalone firm.
Layoffs, Restructuring at GSK
Tracy Vence | Dec 4, 2014
GlaxoSmithKline is eliminating 900 US jobs—most in R&D.
Study: Drug Development Costs $2.6B
Kerry Grens | Nov 24, 2014
A new estimate finds the pricetag for taking a drug through the approval process has steadily risen over the past few decades.
Opinion: Research, Restricted
David Nutt | Jul 8, 2013
Are the international drug laws the worst impediment to scientific inquiry since the Catholic Church banned the telescope?
Building a Better Network
Jef Akst | Apr 23, 2013
NIH Director Francis Collins and colleagues announce plans to create a health-care research network to connect patients, doctors, and clinical researchers.
Gold Dust Missing from Pfizer Lab
Jef Akst | Dec 10, 2012
$700,000 worth of gold dust has been reported missing from a Pfizer medical research lab in Missouri.
Medicines for the World
Suerie Moon and Ellen â??t Hoen, Suerie Moon and Ellen â??t Hoen | Oct 1, 2012
A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.